135 related articles for article (PubMed ID: 21714749)
1. New QSAR prediction models derived from GPCR CB2-antagonistic triaryl bis-sulfone analogues by a combined molecular morphological and pharmacophoric approach.
Chen JZ; Myint KZ; Xie XQ
SAR QSAR Environ Res; 2011; 22(5-6):525-44. PubMed ID: 21714749
[TBL] [Abstract][Full Text] [Related]
2. Optimization of triaryl bis-sulfones as cannabinoid-2 receptor ligands.
Lavey BJ; Kozlowski JA; Shankar BB; Spitler JM; Zhou G; Yang DY; Shu Y; Wong MK; Wong SC; Shih NY; Wu J; McCombie SW; Rizvi R; Wolin RL; Lunn CA
Bioorg Med Chem Lett; 2007 Jul; 17(13):3760-4. PubMed ID: 17466519
[TBL] [Abstract][Full Text] [Related]
3. Fragment-similarity-based QSAR (FS-QSAR) algorithm for ligand biological activity predictions.
Myint KZ; Ma C; Wang L; Xie XQ
SAR QSAR Environ Res; 2011 Jun; 22(3):385-410. PubMed ID: 21598200
[TBL] [Abstract][Full Text] [Related]
4. The application of 3D-QSAR studies for novel cannabinoid ligands substituted at the C1' position of the alkyl side chain on the structural requirements for binding to cannabinoid receptors CB1 and CB2.
Durdagi S; Kapou A; Kourouli T; Andreou T; Nikas SP; Nahmias VR; Papahatjis DP; Papadopoulos MG; Mavromoustakos T
J Med Chem; 2007 Jun; 50(12):2875-85. PubMed ID: 17521177
[TBL] [Abstract][Full Text] [Related]
5. 3D-QSAR studies of arylpyrazole antagonists of cannabinoid receptor subtypes CB1 and CB2. A combined NMR and CoMFA approach.
Chen JZ; Han XW; Liu Q; Makriyannis A; Wang J; Xie XQ
J Med Chem; 2006 Jan; 49(2):625-36. PubMed ID: 16420048
[TBL] [Abstract][Full Text] [Related]
6. Triaryl bis-sulfones as a new class of cannabinoid CB2 receptor inhibitors: identification of a lead and initial SAR studies.
Lavey BJ; Kozlowski JA; Hipkin RW; Gonsiorek W; Lundell DJ; Piwinski JJ; Narula S; Lunn CA
Bioorg Med Chem Lett; 2005 Feb; 15(3):783-6. PubMed ID: 15664857
[TBL] [Abstract][Full Text] [Related]
7. Expansion of SAR studies on triaryl bis sulfone cannabinoid CB2 receptor ligands.
Tong L; Shankar BB; Chen L; Rizvi R; Kelly J; Gilbert E; Huang C; Yang DY; Kozlowski JA; Shih NY; Gonsiorek W; Hipkin RW; Malikzay A; Lunn CA; Lundell DJ
Bioorg Med Chem Lett; 2010 Nov; 20(22):6785-9. PubMed ID: 20850969
[TBL] [Abstract][Full Text] [Related]
8. Triaryl bis-sulfones as cannabinoid-2 receptor ligands: SAR studies.
Shankar BB; Lavey BJ; Zhou G; Spitler JA; Tong L; Rizvi R; Yang DY; Wolin R; Kozlowski JA; Shih NY; Wu J; Hipkin RW; Gonsiorek W; Lunn CA
Bioorg Med Chem Lett; 2005 Oct; 15(20):4417-20. PubMed ID: 16115769
[TBL] [Abstract][Full Text] [Related]
9. GPCR structure-based virtual screening approach for CB2 antagonist search.
Chen JZ; Wang J; Xie XQ
J Chem Inf Model; 2007; 47(4):1626-37. PubMed ID: 17580929
[TBL] [Abstract][Full Text] [Related]
10. TOMOCOMD-CARDD descriptors-based virtual screening of tyrosinase inhibitors: evaluation of different classification model combinations using bond-based linear indices.
Casañola-Martín GM; Marrero-Ponce Y; Khan MT; Ather A; Sultan S; Torrens F; Rotondo R
Bioorg Med Chem; 2007 Feb; 15(3):1483-503. PubMed ID: 17110117
[TBL] [Abstract][Full Text] [Related]
11. Non-aromatic A-ring replacement in the triaryl bis-sulfone CB2 receptor inhibitors.
Gilbert EJ; Zhou G; Wong MK; Tong L; Shankar BB; Huang C; Kelly J; Lavey BJ; McCombie SW; Chen L; Rizvi R; Dong Y; Shu Y; Kozlowski JA; Shih NY; Hipkin RW; Gonsiorek W; Malikzay A; Lunn CA; Favreau L; Lundell DJ
Bioorg Med Chem Lett; 2010 Jan; 20(2):608-11. PubMed ID: 20005710
[TBL] [Abstract][Full Text] [Related]
12. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y
J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304
[TBL] [Abstract][Full Text] [Related]
13. Three-dimensional quantitative structure-selectivity relationships analysis guided rational design of a highly selective ligand for the cannabinoid receptor 2.
Brogi S; Corelli F; Di Marzo V; Ligresti A; Mugnaini C; Pasquini S; Tafi A
Eur J Med Chem; 2011 Feb; 46(2):547-55. PubMed ID: 21183257
[TBL] [Abstract][Full Text] [Related]
14. Virtual screening of biogenic amine-binding G-protein coupled receptors: comparative evaluation of protein- and ligand-based virtual screening protocols.
Evers A; Hessler G; Matter H; Klabunde T
J Med Chem; 2005 Aug; 48(17):5448-65. PubMed ID: 16107144
[TBL] [Abstract][Full Text] [Related]
15. Combinatorial QSAR modeling of specificity and subtype selectivity of ligands binding to serotonin receptors 5HT1E and 5HT1F.
Wang XS; Tang H; Golbraikh A; Tropsha A
J Chem Inf Model; 2008 May; 48(5):997-1013. PubMed ID: 18470978
[TBL] [Abstract][Full Text] [Related]
16. Application of predictive QSAR models to database mining: identification and experimental validation of novel anticonvulsant compounds.
Shen M; Béguin C; Golbraikh A; Stables JP; Kohn H; Tropsha A
J Med Chem; 2004 Apr; 47(9):2356-64. PubMed ID: 15084134
[TBL] [Abstract][Full Text] [Related]
17. Homology modeling in tandem with 3D-QSAR analyses: a computational approach to depict the agonist binding site of the human CB2 receptor.
Cichero E; Ligresti A; Allarà M; di Marzo V; Lazzati Z; D'Ursi P; Marabotti A; Milanesi L; Spallarossa A; Ranise A; Fossa P
Eur J Med Chem; 2011 Sep; 46(9):4489-505. PubMed ID: 21835510
[TBL] [Abstract][Full Text] [Related]
18. Development of CoMFA and CoMSIA models of affinity and selectivity for indole ligands of cannabinoid CB1 and CB2 receptors.
De Freitas GB; da Silva LL; Romeiro NC; Fraga CA
Eur J Med Chem; 2009 Jun; 44(6):2482-96. PubMed ID: 19249138
[TBL] [Abstract][Full Text] [Related]
19. A quantitative structure-activity relationship (QSAR) study of dermal absorption using theoretical molecular descriptors.
Basak SC; Mills D; Mumtaz MM
SAR QSAR Environ Res; 2007; 18(1-2):45-55. PubMed ID: 17365958
[TBL] [Abstract][Full Text] [Related]
20. Unified QSAR approach to antimicrobials. Part 3: first multi-tasking QSAR model for input-coded prediction, structural back-projection, and complex networks clustering of antiprotozoal compounds.
Prado-Prado FJ; González-Díaz H; de la Vega OM; Ubeira FM; Chou KC
Bioorg Med Chem; 2008 Jun; 16(11):5871-80. PubMed ID: 18485714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
